B-type natriuretic peptide (BNP) attenuates the L-type calcium current and regulates ventricular myocyte function

R Sodi, E Dubuis, A Shenkin, G Hart - Regulatory peptides, 2008 - Elsevier
A fundamental question in physiology is how hormones regulate the functioning of a cell or
organ. It was therefore the aim of this study to investigate the effect (s) of BNP-32 on calcium …

[PDF][PDF] Molecular characterisation and functional interrogation of a local natriuretic peptide system in rodent pituitaries, aT3-1 and LbT2 gonadotroph cells

IR Thompson, AN Chand, KC Jonas… - Journal of …, 2009 - academia.edu
In the pituitary, C-type natriuretic peptide (CNP) has been implicated as a gonadotroph-
specific factor, yet expression of the CNP gene (Nppc) and CNP activity in gonadotrophs is …

Functional modulation of sarcolemmal KATP channels by atrial natriuretic peptide-elicited intracellular signaling in adult rabbit ventricular cardiomyocytes

DM Zhang, YF Lin - American Journal of Physiology-Cell …, 2020 - journals.physiology.org
ATP-sensitive potassium (KATP) channels couple cell metabolic status to membrane
excitability and are crucial for stress adaptation and cytoprotection in the heart. Atrial …

[HTML][HTML] Amyloidosis in surgically resected atrial appendages: a study of 345 consecutive cases with clinical implications

AU Fayyaz, MC Bois, S Dasari, D Padmanabhan… - Modern Pathology, 2020 - Elsevier
Histomorphologic parameters of atrial appendages removed during the Cox-Maze
procedure have been shown to correlate with recurrence of atrial fibrillation. While amyloid …

Incidence of hyperkalemia in anuric hemodialysis patients treated with sacubitril/valsartan

X Li, F Ma, Y Wang, H Zhao, J Gao - Hemodialysis International, 2024 - Wiley Online Library
Introduction Sacubitril/valsartan is increasingly used in hemodialysis patients due to its
cardioprotective benefits. However, its impact on serum potassium levels in anuric patients …

Kir6.2-deficient mice are susceptible to stimulated ANP secretion: KATP channel acts as a negative feedback mechanism?

N Saegusa, T Sato, T Saito, M Tamagawa… - Cardiovascular …, 2005 - academic.oup.com
Objective: While atrial natriuretic peptide (ANP) has been shown to be released mainly from
cardiac muscle cells in response to atrial distension, the regulatory mechanisms of ANP …

[HTML][HTML] Milestones in heart failure: how far we have come and how far we have left to go

H Gajjela, I Kela, CL Kakarala, M Hassan, R Belavadi… - Cureus, 2021 - ncbi.nlm.nih.gov
Heart failure is a clinically complex syndrome that results due to the failure of the ventricles
to function as pump and oxygenate end organs. The repercussions of inadequate perfusion …

NT-proBNP cardiac value in COVID-19: a focus on the paediatric population

B Sleem, C El Rassi, R Zareef, F Bitar… - Cardiology in the …, 2024 - cambridge.org
NT-proBNP is a peptide related to brain natriuretic peptide, a cardiac biomarker and a
member of the natriuretic family of peptides. NT-proBNP has demonstrated its clinical utility …

[HTML][HTML] Dysfunction of atrial and B-type natriuretic peptides in congenital univentricular defects

LS Sun, C Dominguez, NA Mallavaram… - The Journal of Thoracic …, 2005 - Elsevier
OBJECTIVE: To examine whether children with univentricular defects have intrinsic
dysfunction in the natriuretic peptide system. METHODS: We compared plasma levels of the …

[PDF][PDF] Natriuretic peptides as therapy in cardiac ischaemia/reperfusion

BS Kousholt - Dan Med J, 2012 - content.ugeskriftet.dk
INTRODUCTION Despite extraordinary advances in both preventive and clinical medicine
acute myocardial infarction (AMI) is a leading cause of mortality in modern societies (1-3) …